Investigation of polymorphisms in pre-eclampsia related genes VEGF and IL1A

Archives of Gynecology and Obstetrics

Volumn 291, Issue 5, 2015, Pages 1029-1035

  Silva, Vanessa Resende Souza ^a   Soardi, Fernanda Caroline ^a,b   Tanaka, Sarah Cristina Sato Vaz ^a   da Silva Grecco, Roseane Lopes ^a   Paschoini, Marina Carvalho ^a   Balarin, Marly Aparecida Spadotto ^a  

^a FEDERAL UNIVERSITY OF TRIÂNGULO MINEIRO   (Brazil)

^b UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

IL1A; Polymorphisms; Pre eclampsia; VEGF

Indexed keywords

AGAROSE; INTERLEUKIN 1ALPHA; POLYACRYLAMIDE GEL; VASCULOTROPIN; VASCULOTROPIN A;

ADULT; ARTICLE; BRAZILIAN; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC CORRELATION; GENETIC POLYMORPHISM; HUMAN; INTERLEUKIN 1 ALPHA GENE; MAJOR CLINICAL STUDY; MOLECULAR PATHOLOGY; POLYMERASE CHAIN REACTION; PREECLAMPSIA; PREGNANT WOMAN; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; VASCULAR ENDOTHELIAL GROWTH FACTOR GENE; YOUNG ADULT; ALLELE; BRAZIL; GENETICS; METABOLISM; PREGNANCY;

ADULT; ALLELES; BRAZIL; FEMALE; HUMANS; INTERLEUKIN-1ALPHA; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PRE-ECLAMPSIA; PREGNANCY; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84925003903     PISSN: 09320067     EISSN: 14320711     Source Type: Journal    
DOI: 10.1007/s00404-014-3503-2     Document Type: Article

References (53)

1. Laurenti R, Jorge MHPM, Gotlieb SLD (2004) A mortalidade materna nas capitais brasileiras: algumas características e estimativa de um fator de ajuste. Rev Bras Epidemiol 7:449–460
2. Polsani S, Phipps E, Jim B (2013) Emerging new biomarkers of preeclampsia. Adv Chronic Kidney Dis 20(3):271–279. doi:10.1053/j.ackd.2013.01.001
3. Saftlas AF, Olson DR, Franks AL, Atrash HK, Pokras R (1990) Epidemiology of preeclampsia and eclampsia in the United States, 1979-1986. Am J Obstet Gynecol 163(2):460–465
4. Winn VD, Gormley M, Paquet AC, Kjaer-Sorensen K, Kramer A, Rumer KK, Haimov-Kochman R, Yeh RF, Overgaard MT, Varki A, Oxvig C, Fisher SJ (2009) Severe preeclampsia-related changes in gene expression at the maternal-fetal interface include sialic acid-binding immunoglobulin-like lectin-6 and pappalysin-2. Endocrinology 150(1):452–462. doi:10.1210/en.2008-0990
5. Chambers JC, Fusi L, Malik IS, Haskard DO, De Swiet M, Kooner JS (2001) Association of maternalendothelial dysfunction with preeclampsia. JAMA 285(12):1607–1612
6. Noris M, Perico N, Remuzzi G (2005) Mechanisms of disease: preeclampsia. Nat Clin Pract Nephrol 1(2):98–114 (Review)
7. Barton JR, Sibai BM (2008) Prediction and prevention of preeclampsia. Obstet Gynecol 112:359–372. doi:10.1097/AOG.0b013e3181801d56 (Review)
8. Dekker G, Robillard PY, Roberts C (2011) The etiology of preeclampsia: the role of the father. J Reprod Immunol 89(2):126–132. doi:10.1016/j.jri.2010.12.010
9. Benjamin F, Craig CJ (1961) Uterine distension and pre-eclamptic toxaemia. J Obstet Gynaecol Br Emp 68:827–830
10. Robertson WB, Brosens I, Landells WN (1985) Abnormal placentation. Obstet Gynecol Annu 14:411–426
11. Terao T, Maki M, Ikenoue T, Gotoh K, Murata M, Iwasaki H, Shibata J, Nakabayashi M, Muraoka M, Takeda Y et al (1991) The relationship between clinical signs and hypercoagulable state in toxemia of pregnancy. Gynecol Obstet Invest 31(2):74–85
12. Dekker GA, Sibai BM (1998) Etiology and pathogenesis of preeclampsia: current concepts. Am J Obstet Gynecol 179(5):1359–1375 (Review)
13. Higgins JR, Brennecke SP (1998) Pre-eclampsia—still a disease of theories? Curr Opin Obstet Gynecol 10(2):129–133 (Review)
14. Redman CW, Sacks GP, Sargent IL (1999) Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol 180(2 Pt 1):499–506
15. Faas MM, Schuiling GA (2001) Pre-eclampsia and the inflammatory response. Eur J Obstet Gynecol Reprod Biol 95(2):213–217 (Review)
16. Kupferminc MJ (2003) Thrombophilia and pregnancy. Reprod Biol Endocrinol 14(1):111
17. Fisher SJ (2004) The placental problem: linking abnormal cytotrophoblast differentiation to the maternal symptoms of preeclampsia. Reprod Biol Endocrinol 2:53. doi:10.1186/1477-7827-2-53
18. Myatt L, Cui X (2004) Oxidative stress in the placenta. Histochem Cell Biol 122(4):369–382 (Review)
19. Shah DM (2005) Role of the renin-angiotensin system in the pathogenesis of preeclampsia. Am J Physiol Renal Physiol 288(4):F614–F625
20. Conrad KP, Benyo DF (1997) Placental cytokines and the pathogenesis of preeclampsia. Am J Reprod Immunol 37(3):240–249 (Review)
21. Redman CW, Sargent IL (2009) Placental stress and preeclampsia: a revised view. Placenta 30(Suppl)A:S38–S42. doi:10.1016/j.placenta.2008.11.021
22. Ward K, Hata A, Jeunemaitre X, Helin C, Nelson L, Namikawa C, Farrington PF, Ogasawara M, Suzumori K, Tomoda S et al (1993) A molecular variant of angiotensinogen associated with preeclampsia. Nat Genet 4(1):59–61
23. Chen G, Wilson R, Wang SH, Zheng HZ, Walker JJ, Mckillop JH (1996) Tumor necrosis factor-alpha (TNF-alpha) gene polymorphism and expression in pre-eclampsia. Clin Exp Immunol 104(1):154–159
24. Grandone E, Margaglione M, Colaizzo D, Cappucci G, Paladini D, Martinelli P, Montanaro S, Pavone G, Di Minno G (1997) Factor V Leiden, C > T MTHFR polymorphism and genetic susceptibility to preeclampsia. Thromb Haemost 77(6):1052–1054
25. Laivuori H, Kaaja R, Ylikorkala O, Hiltunen T, Kontula K (2000) 677 C > T polymorphism of the methylenetetrahydrofolate reductase gene and preeclampsia. Obstet Gynecol 96(2):277–280
26. Huber A, Grimm C, Jirecek S, Zeillinger R, Husslein P, Hefler L (2005) Polymorphisms within the interleukin-1 gene family and unexplained late intrauterine fetal death: a multi-center study. Am J Reprod Immunol 53(3):132–135
27. Chappell S, Morgan L (2006) Searching for genetic clues to the causes of preeclampsia. Clin Sci (Lond) 110(4):443–458
28. Ferrara N, Henzel WJ (2012) Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun 425(3):540–547. doi:10.1016/j.bbrc.2012.08.02
29. Papapetropoulos A, García-Cardeña G, Madri JA, Sessa WC (1997) Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells. J Clin Invest 100(12):3131–3139
30. Vincenti V, Cassano C, Rocchi M, Persico G (1996) Assignment of the vascular endothelial growth factor gene to human chromosome 6p21.3. Circulation 93(8):1493–1495
31. Kasahara Y, Tuder RM, Taraseviciene-Stewart L, Le Cras TD, Abman S, Hirth PK, Waltenberger J, Voelkel NF (2000) Inhibition of VEGF receptors causes lung cell apoptosis and emphysema. J Clin Invest 106(11):1311–1319
32. Papazoglou D, Galazios G, Koukourakis MI, Panagopoulos I, Kontomanolis EN, Papatheodorou K, Maltezos E (2004) Vascular endothelial growth factor gene polymorphisms and pré-eclampsia. Mol Hum Reprod 10(5):321–324
33. Bányász I, Szabó S, Bokodi G, Vannay A, Vásárhelyi B, Szabó A, Tulassay T, Rigó J Jr (2006) Genetic polymorphisms of vascular endothelial growth factor in severe pré-eclampsia V. Mol Hum Reprod 12(4):233–236
34. Shim JY, Jun JK, Jung BK, Kim SH, Won HS, Lee PR, Kim A (2007) Vascular endothelial growth factor gene +936 C/T polymorphism is associated with preeclampsia in Korean women. Am J Obstet Gynecol 197(3):271
35. Sandrim VC, Palei AC, Cavalli RC, Araújo FM, Ramos ES, Duarte G, Tanus-Santos JE (2009) Vascular endothelial growth factor genotypes and haplotypes are associated with pre-eclampsia but not with gestacional hypertension. Mol Hum Reprod 15(2):115–120. doi:10.1093/molehr/gan076
36. Awata T, Inoue K, Kurihara S, Ohkubo T, Watanabe M, Inukai K, Inoue I, Katayama S (2002) A common polymorphism in the 5′-untranslated region of the VEGF gene is associated with diabetic retinopathy in type 2 diabetes. Diabetes 51(5):1635–1639
37. Cotran RS, Pober JS (1990) Cytokine-endothelial interactions in inflammation, immunity, and vascular injury. J Am Soc Nephrol 1(3):225–235
38. Pober JS, Cotran RS (1990) Cytokines and endothelial cell biology. Physiol Rev 70(2):427–451 (Review)
39. Dinarello CA (1998) Interleukin-1, interleukin-1 receptors and interleukin-1 receptor antagonist. Int Rev Immunol 16(5–6):457–499 (Review)
40. Goddard KA, Tromp G, Romero R, Olson JM, Lu Q, Xu Z, Parimi N, Nien JK, Gomez R, Behnke E, Solari M, Espinoza J, Santolaya J, Chaiworapongsa T, Lenk GM, Volkenant K, Anant MK, Salisbury BA, Carr J, Lee MS, Vovis GF, Kuivaniemi H (2007) Candidate-gene association study of mothers with pre-eclampsia, and their infants, analyzing 775 SNPs in 190 genes. Hum Hered 63(1):1–16
41. Sambrook J, Fritsch EF, Maniatis TE (1989) Molecular cloning, a laboratory manual. Cold Spring Harbor, New York
42. Faul F, Erdfelder E, Lang AG, Buchner A (2007) G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 39:175–191
43. Cnattingius S, Reilly M, Pawitan Y, Lichtenstein P (2004) Maternal and fetal genetic factors account for most of familial aggregation of preeclampsia: a population-based Swedish cohort study. Am J Med Genet A 130A(4):365–371
44. Staines-Urias E, Paez MC, Doyle P, Dudbridge F, Serrano NC, Ioannidis JP, Keating BJ, Hingorani AD, Casas JP (2012) Genetic association studies in pre-eclampsia: systematic meta-analyses and field synopsis. Int J Epidemiol 41(6):1764–1775. doi:10.1093/ije/dys162
45. Luizon MR, Sandrim VC, Palei AC, Lacchini R, Cavalli RC, Duarte G, Tanus-Santos JE (2012) Epistasis among eNOS, MMP-9 and VEGF maternal genotypes in hypertensive disorders of pregnancy. Hypertens Res 35(9):917–921. doi:10.1038/hr.2012.60
46. Chedraui P, Solis EJ, Bocci G, Gopal S, Russo E, Escobar GS, Hidalgo L, Pérez-López FR, Genazzani AR, Mannella P, Simoncini T (2013) Feto-placental nitric oxide, asymmetric dimethylarginine and vascular endothelial growth factor (VEGF) levels and VEGF gene polymorphisms in severe preeclampsia. J Matern Fetal Neonatal Med 26(3):226–232. doi:10.3109/14767058.2012.733760
47. Cunha VM, Grecco RL, Paschoini MC, Silva SR, Ruiz MT, Balarin MA (2011) Genetic polymorphisms of vascular endothelial growth factor in preeclampsia. Rev Bras Ginecol Obstet 33(7):158–163
48. Darmochwal-Kolarz D, Rolinski J, Leszczynska-Goarzelak B, Oleszczuk J (2002) The expressions of intracellular cytokines in the lymphocytes of preeclamptic patients. Am J Reprod Immunol 48(6):381–386
49. Li J, Liu M, Zong J, Tan P, Wang J, Wang X, Ye Y, Liu S, Liu X (2014) Genetics variations in IL1A and IL1RN are associated with the risk of preeclampsia in Chinese Han population. Sci Rep 4:5250. doi:10.1038/screp05250
50. Haggerty CL, Ferrell RE, Hubel CA, Markovic N, Harger G, Ness RB (2005) Association between allelic variants in cytokine genes and preeclampsia. Am J Obstet Gynecol 193(1):209–215
51. Faisel F, Romppanen EL, Hiltunen M, Helisalmi S, Punnonen K, Salonen J, Heinonen S (2003) Polymorphism in the interleukin 1 receptor antagonist gene in women with preeclampsia. J Reprod Immunol 60(1):61–70
52. Hefler LA, Tempfer CB, Gregg AR (2001) Polymorphisms within the interleukin-1 beta gene cluster and pre-eclampsia. Obstet Gynecol 97(5 Pt 1):664–668
53. Combarros O, Infante J, Llorca J, Peña N, Fernández-Viadero C, Berciano J (2005) Interaction between interleukin-6 and intercellular adhesion molecule-1 genes and Alzheimer’s disease risk. J Neurol 252(4):485–487